CClinicalTrials.gg
CompletedNCT05623631Updated Nov 21, 2022

Delphi Study to Identify Crucial Steps and Errors in the Placement of Chest Tubes

An interventional study of Survey in Thoracic Injury, sponsored by University Ghent. Completed at 1 site in Belgium. Per ClinicalTrials.gov, last updated 2022-11-21.

Sponsored by University Ghent · Not applicable, Interventional, and Other

From the registry’s dates

  • Registered 1 year 7 months after the study started (first participant enrolled Mar 2021, registered Nov 2022).
Phase
Not applicable
Study type
Interventional
Enrollment
29
Allocation
Not applicable
Sex
All
01

Study summary

The goal of this Delphi study is to identify the crucial steps and the errors in Chest Tube Insertion (CTI). These steps and errors will be used for the development of a new assessment tool based on international consensus.

02

Conditions studied

  • Thoracic Injury

Browse trials for

Keywords

  • Assessment
  • Chest Tube Insertion
  • Rating Scale
03

In context

Thoracic Injuries

84 studies on the registry are indexed under Thoracic Injuries; 23 are open to participants now.

This study's enrollment of 29 is below the median of 71 across 50 interventional studies indexed under Thoracic Injuries.

Browse Thoracic Injuries studies →

Lead sponsor

University Ghent is the lead sponsor of 345 studies on the registry; 85 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Must be experts in their respective fields.
  • Must hold a degree of Master in Medicine
  • Must have finished the residency training specific to their field (be an attending physician)
  • Must have 5 years post-residency experience
  • Must have performed at least 50 CTIs independently in their career
  • Must have an interest in educating and guiding junior residents in their training.

Exclusion criteria

Exclusion Criteria:

  • Insufficient experience in CTI
  • Insufficient experience as an attending physician
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
29 participants (actual)

Study arms

  • Other
    Delphi study

    Participants were asked to complete three rounds of surveys. These surveys collected information on which steps and errors can occur during CTI, and which of these should be included in an assessment tool.

    Other: Survey

Interventions

  • OtherSurvey

    Surveys were distributed using REDCap, and participants were asked to complete these within 5 weeks of receiving the invitation.

06

What researchers measure

Primary outcomes

  1. Steps and errors presented in round 1

    The number of experts who propose a certain step or error

    Time frame: one year

  2. Number of steps and errors passing round 2

    The number of experts who agree on the inclusion of each step or error in the assessment tool on a 5-point Likert scale (Strongly disagree - Disagree - Neutral - Agree - Strongly Agree).

    Time frame: one year

  3. Inclusion of steps with their descriptive anchors

    The number of experts who agree on the inclusion of each step with their descriptive anchors in the assessment tool on a 5-point Likert scale (Strongly disagree - Disagree - Neutral - Agree - Strongly Agree).

    Time frame: one year

07

Study locations

1 site
  • Ghent University Hospital
    Ghent, Oost-Vlaanderen 9000, Belgium
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 21, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05623631
Lead sponsor
University Ghent
Responsible party
Sponsor
First posted
Nov 21, 2022
Start date
Mar 30, 2021
Primary completion
Sep 28, 2021
Completion
Sep 28, 2021
Last update
Nov 21, 2022

Study contacts

Wouter Willaert, Prof, Dr.
principal investigator · University Ghent

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion